Matthew Wright

2.5k total citations
85 papers, 1.8k citations indexed

About

Matthew Wright is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Matthew Wright has authored 85 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 19 papers in Molecular Biology and 19 papers in Pharmacology. Recurrent topics in Matthew Wright's work include Drug Transport and Resistance Mechanisms (21 papers), Pharmacogenetics and Drug Metabolism (19 papers) and Blood Coagulation and Thrombosis Mechanisms (10 papers). Matthew Wright is often cited by papers focused on Drug Transport and Resistance Mechanisms (21 papers), Pharmacogenetics and Drug Metabolism (19 papers) and Blood Coagulation and Thrombosis Mechanisms (10 papers). Matthew Wright collaborates with scholars based in United States, Canada and France. Matthew Wright's co-authors include Fakhreddin Jamali, Cornelis E. C. A. Hop, Ruth R. Wexler, Robert M. Knabb, Pancras C. Wong, Xingrong Liu, Richard Alexander, Donald Pinto, Patrick Y. S. Lam and Mimi L. Quan and has published in prestigious journals such as Neuron, Analytical Chemistry and Biometrics.

In The Last Decade

Matthew Wright

82 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew Wright United States 25 472 352 342 284 249 85 1.8k
Mark J. Rose United States 23 794 1.7× 334 0.9× 195 0.6× 239 0.8× 276 1.1× 49 2.7k
Jürgen Venitz United States 29 1.1k 2.3× 607 1.7× 152 0.4× 178 0.6× 240 1.0× 87 2.9k
John F. Gilmer Ireland 23 532 1.1× 337 1.0× 317 0.9× 70 0.2× 62 0.2× 68 1.7k
Kevin B. Alton United States 26 691 1.5× 545 1.5× 214 0.6× 501 1.8× 37 0.1× 49 2.8k
Nuala A. Helsby New Zealand 26 719 1.5× 382 1.1× 156 0.5× 522 1.8× 71 0.3× 81 2.0k
Tycho Heimbach United States 28 1.1k 2.3× 618 1.8× 360 1.1× 613 2.2× 141 0.6× 70 3.4k
Gian Camenisch Switzerland 26 871 1.8× 915 2.6× 318 0.9× 525 1.8× 83 0.3× 56 2.5k
Daniel S. Zaharko United States 27 1.0k 2.2× 552 1.6× 152 0.4× 367 1.3× 199 0.8× 64 2.7k
Christopher Banfield United States 30 328 0.7× 515 1.5× 62 0.2× 425 1.5× 118 0.5× 88 2.8k
Yu‐Sheng Chao Taiwan 36 1.6k 3.4× 541 1.5× 533 1.6× 148 0.5× 66 0.3× 98 3.7k

Countries citing papers authored by Matthew Wright

Since Specialization
Citations

This map shows the geographic impact of Matthew Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Wright more than expected).

Fields of papers citing papers by Matthew Wright

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Wright. The network helps show where Matthew Wright may publish in the future.

Co-authorship network of co-authors of Matthew Wright

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Wright. A scholar is included among the top collaborators of Matthew Wright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Wright. Matthew Wright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Chen, Weiping Zhao, Lin Cao, et al.. (2025). Property-Based Prediction Uncovers Intestinal Excretion as an Elimination Route of Small-Molecule Drugs. Journal of Medicinal Chemistry. 68(16). 17574–17586. 1 indexed citations
2.
Wilson, M, et al.. (2023). Analysis of skin condition emergency department outcomes via the free Healthline service from Whakarongorau Aotearoa. New Zealand Medical Journal. 136(1586). 32–50. 1 indexed citations
3.
Zhang, Donglu, Cong Wei, Cornelis E. C. A. Hop, et al.. (2021). Intestinal Excretion, Intestinal Recirculation, and Renal Tubule Reabsorption Are Underappreciated Mechanisms That Drive the Distribution and Pharmacokinetic Behavior of Small Molecule Drugs. Journal of Medicinal Chemistry. 64(11). 7045–7059. 19 indexed citations
4.
Wright, Matthew. (2021). Opportunities and Considerations in the Application of Artificial Intelligence to Pharmacokinetic Prediction. Methods in molecular biology. 2390. 461–482. 9 indexed citations
5.
Chen, Yi‐Chen, Jane R. Kenny, Matthew Wright, Cornelis E. C. A. Hop, & Zhengyin Yan. (2018). Improving Confidence in the Determination of Free Fraction for Highly Bound Drugs Using Bidirectional Equilibrium Dialysis. Journal of Pharmaceutical Sciences. 108(3). 1296–1302. 28 indexed citations
6.
Wang, Zhulun, Daqing Sun, Sheree Johnstone, et al.. (2015). Discovery of potent, selective, and orally bioavailable inhibitors of interleukin-1 receptor-associate kinase-4. Bioorganic & Medicinal Chemistry Letters. 25(23). 5546–5550. 6 indexed citations
7.
Chang, Jae H., Justin Q. Ly, Emile G. Plise, et al.. (2014). Differential Effects of Rifampin and Ketoconazole on the Blood and Liver Concentration of Atorvastatin in Wild-Type and Cyp3a and Oatp1a/b Knockout Mice. Drug Metabolism and Disposition. 42(6). 1067–1073. 23 indexed citations
8.
Samadfam, Rana, Agnès Bénardeau, Frieder Bauss, et al.. (2011). Combination treatment with pioglitazone and fenofibrate attenuates pioglitazone-mediated acceleration of bone loss in ovariectomized rats. Journal of Endocrinology. 212(2). 179–186. 12 indexed citations
9.
Ansede, John H., Matthew Wright, Robert L. St. Claire, et al.. (2009). Characterization of Sandwich-Cultured Hepatocytes As an in Vitro Model to Assess the Hepatobiliary Disposition of Copper. Drug Metabolism and Disposition. 37(5). 969–976. 5 indexed citations
10.
Jin, Haolun, Matthew Wright, Richard Pastor, et al.. (2008). Tricyclic HIV integrase inhibitors: Potent and orally bioavailable C5-aza analogs. Bioorganic & Medicinal Chemistry Letters. 18(4). 1388–1391. 17 indexed citations
11.
Wong, Harvey, James E. Grace, Matthew Wright, et al.. (2006). Glucuronidation in the chimpanzee (Pan troglodytes): Studies with acetaminophen, oestradiol and morphine. Xenobiotica. 36(12). 1178–1190. 5 indexed citations
12.
Wong, Harvey, Scott Grossman, Stephen A. Bai, et al.. (2004). THE CHIMPANZEE (PAN TROGLODYTES) AS A PHARMACOKINETIC MODEL FOR SELECTION OF DRUG CANDIDATES: MODEL CHARACTERIZATION AND APPLICATION. Drug Metabolism and Disposition. 32(12). 1359–1369. 21 indexed citations
13.
Quan, Mimi L., Christopher D. Ellis, Ann Y. Liauw, et al.. (2003). Nonbenzamidine isoxazoline derivatives as factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(6). 1023–1028. 17 indexed citations
14.
Wright, Matthew, et al.. (2002). A Chronic Bile Duct and Intravenous Cannulation Model in Conscious Rabbits for Pharmacokinetic Studies. Journal of Investigative Surgery. 15(2). 81–89. 3 indexed citations
15.
Rodgers, James D., Patrick Y. S. Lam, Barry L. Johnson, et al.. (1998). Design and selection of DMP 850 and DMP 851: the next generation of cyclic urea HIV protease inhibitors. Chemistry & Biology. 5(11). R312–R312. 1 indexed citations
16.
Davies, Neal M., Matthew Wright, & Fakhreddin Jamali. (1994). Antiinflammatory Drug-Induced Small Intestinal Permeability: The Rat Is a Suitable Model. Pharmaceutical Research. 11(11). 1652–1656. 40 indexed citations
17.
Yeleswaram, Krishnaswamy, D. W. Rurak, Eddie Kwan, et al.. (1993). Transplacental and nonplacental clearances, metabolism and pharmacodynamics of labetalol in the fetal lamb after direct intravenous administration.. Journal of Pharmacology and Experimental Therapeutics. 267(1). 425–431. 10 indexed citations
18.
Wright, Matthew & Fakhreddin Jamali. (1993). Methods for the analysis of enantiomers of racemic drugs application to pharmacological and pharmacokinetic studies. Journal of Pharmacological and Toxicological Methods. 29(1). 1–9. 23 indexed citations
19.
Awbrey, B J, et al.. (1993). The Role of Alpha-1-Protease Inhibitor (A1PI) in the Inhibition of Protease Activity in Human Knee Osteoarthritis. Birkhäuser Basel eBooks. 39. 167–171. 3 indexed citations
20.
Wright, Matthew, et al.. (1982). MICRO-VASCULAR CHANGES PRODUCED BY PROSTAGLANDIN-E1. UCL Discovery (University College London). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026